China Biologic Products Holdings, Inc.

CBPO

Delisted

CBPO was delisted on the 20th of April, 2021.

#	Name	Holding	Trade Value	Shares Change	Change in Stake
1	WP 1 Warburg Pincus New York	$255M	+$277M	+10,989,200	New
2	2 T. Rowe Price Associates Baltimore, Maryland	$4.06M	+$4.46M	+176,729	New
3	3 HSBC Holdings London, United Kingdom	$3.44M	+$3.79M	+150,000	New
4	BIT 4 BlackRock Institutional Trust San Francisco, California	$2.56M	+$2.79M	+110,403	New
5	5 Invesco Atlanta, Georgia	$2.12M	+$2.31M	+91,413	New
6	6 Renaissance Technologies New York	$1.97M	+$2.14M	+84,800	New
7	VAM 7 Visium Asset Management New York	$919K	+$1.01M	+40,003	New
8	8 California Public Employees Retirement System Sacramento, California	$714K	+$785K	+31,100	New
9	SIM 9 Spark Investment Management New York	$625K	+$689K	+27,300	New
10	GCP 10 GSA Capital Partners London, United Kingdom	$582K	+$633K	+25,093	New
11	PP 11 PDT Partners New York	$563K	+$619K	+24,531	New
12	12 Morgan Stanley New York	$530K	+$577K	+22,848	New
13	BA 13 BlackRock Advisors Wilmington, Delaware	$120K	+$131K	+5,172	New
14	RA 14 Royce & Associates New York	$67K	+$73.2K	+2,900	New
15	BJ 15 BlackRock Japan Tokyo, Japan	$58K	+$62.9K	+2,492	New
16	TRCT 16 Tower Research Capital (TRC) New York	$42K	+$45.3K	+1,794	New
17	OA 17 OFI Advisors Philadelphia, Pennsylvania	$4K	+$4.79K	+190	New
18	18 Citigroup New York	$2K	+$1.82K	+72	New